New combo therapy may offer lasting hay fever relief

NCT ID NCT04502966

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether taking a grass pollen tablet (SLIT) together with the drug dupilumab for 2 years can help adults with moderate to severe hay fever tolerate grass pollen better, even after stopping treatment. About 199 participants were involved. The main goal was to see if this combination reduces nasal allergy symptoms during a pollen challenge one year after treatment ends.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC RHINOCONJUNCTIVITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Royal Brompton Hospital

    London, SW36HP, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.